微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 5.45% | -12.52% | 108.02% | 20/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | 2.62% | -15.21% | -77.12% | 28/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 11.45% | -10.55% | 16.13% | 18/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 9.86% | -10.85% | 58.27% | 18/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 6.23% | -8.78% | 101.62% | 18/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 3.09% | -17.38% | -75.86% | 20/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 12.8% | -11.91% | 15.73% | 12/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 11.06% | -0.81% | 61.93% | 16/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 6.83% | 4.43% | 82.62% | 17/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 3.74% | 22.22% | -74.26% | 17/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 14.53% | -2.68% | 30.31% | 15/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 11.15% | -7.39% | 70.49% | 20/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 6.54% | -3.25% | 113.73% | 30/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 3.06% | -5.85% | -79.5% | 41/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 14.93% | 6.8% | 24% | 41/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 12.04% | 13.05% | 78.11% | 45/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 6.76% | 11% | 108% | 56/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 3.25% | 24.52% | -76.75% | 50/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 13.98% | -30.38% | 31.27% | 61/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 10.65% | -37.21% | 74.88% | 55/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 6.09% | -23.11% | 133.33% | 70/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 2.61% | -20.67% | -87% | 58/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 20.08% | -39.66% | 18.4% | 52/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 16.96% | -30.72% | 114.14% | 33/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 7.92% | -46.23% | 140.73% | 53/141 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 3.29% | -45.98% | -90.11% | 25/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 33.28% | 8.62% | 35.95% | 10/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 24.48% | 1.53% | 66.19% | 4/141 | 10.54% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 14.73% | 5.67% | 141.87% | 6/141 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 6.09% | 8.75% | -80.12% | 6/141 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 30.64% | 19.27% | 27.08% | 17/141 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 24.11% | 19.77% | 72.96% | 2/141 | 9.71% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 13.94% | 28.01% | 148.93% | 2/141 | 4.54% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 5.6% | 39.3% | -78.2% | 4/141 | 2.78% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 25.69% | -16.81% | 27.62% | 20/141 | 14.51% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 20.13% | -28.11% | 84.85% | 3/141 | 9.49% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 10.89% | -39.26% | 170.9% | 9/141 | 6.11% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 4.02% | 2% | -86.98% | 7/141 | 2.74% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 30.88% | -31.15% | 10.29% | 13/141 | 16.44% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 28% | 2% | 56.16% | 1/141 | 8.86% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 17.93% | -9.54% | -60.02% | 2/141 | 6.35% | *ST明德 | 23.29% | 行业排名> |